{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:38:09Z","timestamp":1792521489253,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T00:00:00Z","timestamp":1723420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T00:00:00Z","timestamp":1723420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Patients with immune-mediated rheumatic diseases (IMRDs) have been prioritized for COVID-19 vaccination to mitigate the infection severity risks. Patients with rheumatoid arthritis (RA) are at a high risk of severe COVID-19 outcomes, especially those under immunosuppression or with associated comorbidities. However, few studies have assessed the safety of the COVID-19 vaccine in patients with RA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To evaluate the safety of vaccines against SARS-CoV-2 in patients with RA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This data are from the study \u201cSafety and Efficacy on COVID-19 Vaccine in Rheumatic Diseases,\u201d a Brazilian multicentric prospective phase IV study to evaluate COVID-19 vaccine in IMRDs in Brazil. Adverse events (AEs) in patients with RA of all centers were assessed after two doses of ChAdOx1 (Oxford\/AstraZeneca) or CoronaVac (Sinovac\/Butantan). Stratification of postvaccination AEs was performed using a diary, filled out daily and returned at the end of 28\u00a0days for each dose.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 188 patients with RA were include, 90% female. CoronaVac was used in 109 patients and ChAdOx1 in 79. Only mild AEs were observed, mainly after the first dose. The most common AEs after the first dose were pain at the injection (46,7%), headache (39,4%), arthralgia (39,4%), myalgia (30,5%) and fatigue (26,6%), and ChAdOx1 had a higher frequency of pain at the injection (66% vs 32 %, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) arthralgia (62% vs 22%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and myalgia (45% vs 20%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) compared to CoronaVac. The more common AEs after the second dose were pain at the injection (37%), arthralgia (31%), myalgia (23%), headache (21%) and fatigue (18%). Arthralgia (41,4% vs 25%, <jats:italic>p<\/jats:italic>\u2009=\u20090.02) and pain at injection (51,4% vs 27%, <jats:italic>p<\/jats:italic>\u2009=\u20090.001) were more common with ChAdOx1. No serious AEs were related. With Regard to RA activity level, no significant difference was observed between the three time periods for both COVID-19 vaccines.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In the comparison between the two immunizers in patients with RA, local reactions and musculoskeletal symptoms were more frequent with ChAdOx1 than with CoronaVac, especially after the first dose. In summary, the AE occurred mainly after the first dose, and were mild, like previous data from others immunizing agents in patients with rheumatoid arthritis. Vaccination did not worsen the degree of disease activity.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s42358-024-00397-5","type":"journal-article","created":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T11:03:35Z","timestamp":1723460615000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Safety of CoronaVac and ChAdOx1 vaccines against SARS-CoV-2 in patients with rheumatoid arthritis: data from the Brazilian multicentric study safer"],"prefix":"10.1186","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3073-2929","authenticated-orcid":false,"given":"Vitor Alves","family":"Cruz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jozelia","family":"R\u00eago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketty Lysie Libardi Lira","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira Tatiyama","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula Neves","family":"Burian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laiza Hombre","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia Zon","family":"Pretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle Cristina Filgueira Alves","family":"Batista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Geraldo","family":"Mill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin Gurtler Pinheiro","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina Strauss Estevez","family":"Gadelha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"da Penha Gomes Gouveia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Carolina Sim\u00f5es","family":"Moulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1rbara Oliveira","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Gon\u00e7alves Rodrigues","family":"Aguiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel Smith Sobral","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiza Lorenzoni","family":"Grillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina Deorce","family":"de Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"La\u00eds Pizzol","family":"Pasti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heitor Filipe","family":"Surlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipe","family":"Fa\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isac Ribeiro","family":"Moulaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana de Oliveira","family":"Macab\u00fa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscila Dias Cardoso","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa de Oliveira","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana Freitas","family":"de Aguiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Biegelmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1via Maria Matos Melo Campos","family":"Peixoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiane","family":"Kayser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre Wagner Silva","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlles Heldan","family":"de Moura Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra L\u00facia Euz\u00e9bio","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila Maria Paiva Fran\u00e7a","family":"Telles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"B\u00fchring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel Lima","family":"de Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9rgio Henrique Oliveira","family":"Dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel Elias Basualto","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nat\u00e1lia Seixas","family":"de Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosely Holanda","family":"da Silva Sanches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Luiz","family":"Boechat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nat\u00e1lia Sarzi","family":"Sartori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Hax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas Denardi","family":"D\u00f3ria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Poubel Vieira","family":"de Rezende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia Lino","family":"Baptista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nat\u00e1lia Rodrigues Querido","family":"Fortes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Karla Guedes","family":"de Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00e2mara Santos","family":"Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rejane Maria Rodrigues","family":"de Abreu Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adah Sophia Rodrigues","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana maria","family":"kakehasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Carolina Faria Moreira Gomes","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline Teixeira","family":"de Landa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pollyana Vitoria Thomaz","family":"da Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valderilio Feij\u00f3","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olindo Assis","family":"Martins-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Peruhype-Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"de Medeiros Pinheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odirlei Andr\u00e9","family":"Monticielo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgard Torres","family":"Dos Reis-neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilda Aparecida","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviane Angelina","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9a","family":"Teixeira-Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo Machado","family":"Xavier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia Inoue","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Valim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gecilmara Salviato","family":"Pileggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilzio Antonio","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,12]]},"reference":[{"key":"397_CR1","doi-asserted-by":"publisher","first-page":"911036","DOI":"10.3389\/fmicb.2022.911036","volume":"13","author":"NMS Sansone","year":"2022","unstructured":"Sansone NMS, Boschiero MN, Marson FAL. Epidemiologic profile of severe acute respiratory infection in Brazil during the COVID-19 pandemic: an epidemiological study. Front Microbiol. 2022;13:911036.","journal-title":"Front Microbiol"},{"issue":"7821","key":"397_CR2","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","volume":"584","author":"EJ Williamson","year":"2020","unstructured":"Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430\u20136.","journal-title":"Nature"},{"key":"397_CR3","doi-asserted-by":"crossref","unstructured":"Marques C, Kakehasi AM, Gomides APM, Paiva EDS, Dos Reis Neto ET, Pileggi GCS, et al. A Brazilian cohort of patients with immuno-mediated chronic inflammatory diseases infected by SARS-CoV-2 (ReumaCoV-Brasil Registry): protocol for a prospective, observational study. JMIR Res Protoc. 2020;9(12):e24357.","DOI":"10.2196\/24357"},{"key":"397_CR4","unstructured":"COVID-19 Global Rheumatology Alliance. Healthcare Provider Entered Registries. 2020. https:\/\/rheum-covid.org\/provider-registry-gate\/ (2020). Acesso em: 07 out. 2022."},{"issue":"7","key":"397_CR5","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.annonc.2020.03.300","volume":"31","author":"JM Michot","year":"2020","unstructured":"Michot JM, Albiges L, Chaput N, Saada V, Pommeret F, Griscelli F, et al. Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratoryfailure: a case report. Ann Oncol. 2020;31(7):961\u20134.","journal-title":"Ann Oncol"},{"issue":"10223","key":"397_CR6","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1016\/S0140-6736(20)30304-4","volume":"395","author":"P Richardson","year":"2020","unstructured":"Richardson P, Griffin I, Tucker C, Smith D, Oechsle O, Phelan A, et al. Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. Lancet. 2020;395(10223):e30\u20131.","journal-title":"Lancet"},{"issue":"10","key":"397_CR7","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.3390\/vaccines9101097","volume":"9","author":"Z Yan","year":"2021","unstructured":"Yan Z, Yang M, Lai CL. COVID-19 vaccinations: a comprehensive review of their safety and efficacy in special populations. Vaccines (Basel). 2021;9(10):1097.","journal-title":"Vaccines (Basel)"},{"issue":"33","key":"397_CR8","doi-asserted-by":"publisher","first-page":"4788","DOI":"10.1016\/j.vaccine.2022.06.014","volume":"40","author":"PMN Oliveira","year":"2022","unstructured":"Oliveira PMN, Almeida DPM, Porto VBG, Cordeiro CC, Teixeira GV, Pedro RS, et al. Vaccine-induced immune thrombotic thrombocytopenia after COVID-19 vaccination: description of a series of 39 cases in Brazil. Vaccine. 2022; 40(33):4788\u201395.","journal-title":"Vaccine"},{"key":"397_CR9","doi-asserted-by":"crossref","unstructured":"Bueno SM, Abarca K, Gonz\u00e1lez PA, G\u00e1lvez NMS, Soto JA, Duarte LF, et al. Safety and immunogenicity of na inactivated SARS-CoV-2 vaccine in a subgroup of healthy adults in chile. Clin Infect Dis. 2021;e792\u2013e804.","DOI":"10.1093\/cid\/ciab823"},{"key":"397_CR10","doi-asserted-by":"crossref","unstructured":"Hern\u00e1ndez AF, Calina D, Poulas K, Docea AO, Tsatsakis AM. Safety of COVID-19 vaccines administered in the EU: should we be concerned? Toxicol Rep. 2021;8:871\u20139.","DOI":"10.1016\/j.toxrep.2021.04.003"},{"issue":"5","key":"397_CR11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.rbr.2014.04.002","volume":"54","author":"LF Muniz","year":"2014","unstructured":"Muniz LF, Silva RS, Costa TF, Mota LMH. Vacina\u00e7\u00e3o em pacientes da Coorte Bras\u00edlia de artrite reumatoide inicial. Revista Brasileira de Reumatologia. 2014;54(5):349\u201355.","journal-title":"Revista Brasileira de Reumatologia"},{"issue":"1","key":"397_CR12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1590\/S0482-50042013000100001","volume":"53","author":"CV Brenol","year":"2013","unstructured":"Brenol CV, Mota LMH, Cruz BA, Pileggi GS, Pereira IA, Rezende LS, et al. Consenso 2012 da Sociedade Brasileira de Reumatologia sobre vacinac\u0327a\u0303o em pacientes com artrite reumatoide. Rev Bras Reumatol. 2013;53(1):4\u201323.","journal-title":"Rev Bras Reumatol"},{"issue":"7","key":"397_CR13","doi-asserted-by":"publisher","first-page":"e470","DOI":"10.1016\/S2665-9913(21)00186-7","volume":"3","author":"A Rubbert-Roth","year":"2021","unstructured":"Rubbert-Roth A, Vuilleumier N, Ludewig B, Schmiedeberg K, Haller C, von Kempis J Anti-SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis. Lancet Rheumatol. 2021;3(7):e470\u20132.","journal-title":"Lancet Rheumatol"},{"issue":"1","key":"397_CR14","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/S2665-9913(21)00328-3","volume":"4","author":"K Schmiedeberg","year":"2022","unstructured":"Schmiedeberg K, Vuilleumier N, Pagano S, Albrich WC, Ludewig B, Kempis JV, et al. Efficacy and tolerability of a third dose of an mRNA anti-SARS-CoV-2 vaccine in patients with rheumatoid arthritis with absent or minimal serological response to two previous doses. Lancet Rheumatol. 2022;4(1):e11\u2013e13.","journal-title":"Lancet Rheumatol"},{"key":"397_CR15","doi-asserted-by":"publisher","first-page":"577788","DOI":"10.1016\/j.jneuroim.2021.577788","volume":"362","author":"I Adamec","year":"2022","unstructured":"Adamec I, Rogi\u0107 D, Penz MG, Braun C, Habek M. Humoral and cellular immunity in convalescent COVID-19 people with multiple sclerosis treated with ofatumumab. J Neuroimmunol. 2022;362:577788.","journal-title":"J Neuroimmunol"},{"key":"397_CR16","doi-asserted-by":"crossref","unstructured":"Tavares ACFMG, Melo AKG, Cruz VA, Souza VA, Carvalho JS, Machado KLLL, et al. Guidelines on COVID-19 vaccination in patients with immunemediated rheumatic diseases: a Brazilian society of rheumatology task force. Adv Rheumatol. 2022;62:3.","DOI":"10.1186\/s42358-022-00256-1"},{"key":"397_CR17","unstructured":"Minist\u00e9rio da Sa\u00fade (BR) Secretaria de Vigil\u00e2ncia em Sa\u00fade. Departamento de Imuniza\u00e7\u00e3o e Doen\u00e7as Transmiss\u00edveis. Plano Nacional de Operacionaliza\u00e7\u00e3o da Vacina\u00e7\u00e3o Contra a Covid-19 [Recurso eletr\u00f4nico]\/Minist\u00e9rio da Sa\u00fade, Secretaria de Vigil\u00e2ncia Em Sa\u00fade, Departamento de Imuniza\u00e7\u00e3o E Doen\u00e7as Transmiss\u00edveis. 2. ed. Bras\u00edlia: Minist\u00e9rio da Sa\u00fade, 2022."},{"key":"397_CR18","doi-asserted-by":"crossref","unstructured":"Castelar-Pinheiro GR, Albuquerque CP, B\u00e9rtolo MB, Louzada J\u00fanior P, Giorgi RDN, Radominski SC, et al. The REAL study: a nationwide prospective study of rheumatoid arthritis in Brazil. Adv Rheumatol. 2018;58(9).","DOI":"10.1186\/s42358-018-0017-9"},{"issue":"1","key":"397_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s42358-018-0034-8","volume":"58","author":"RKS Gomes","year":"2018","unstructured":"Gomes RKS, Linhares AC, Lersch LS. Prevalence and factors associated with diagnosis of early rheumatoid arthritis in the south of Brazil. Adv Rheumatol. 2018;58(1):35.","journal-title":"Adv Rheumatol"},{"issue":"3","key":"397_CR20","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1590\/S0482-50042010000300004","volume":"50","author":"LMH Mota","year":"2010","unstructured":"Mota LMH, Laurindo IMM, Santos Neto LL. Caracter\u00edsticas demogr\u00e1ficas e cl\u00ednicas de uma coorte de pacientes com artrite reumatoide inicial. Rev Bras Reumatol. 2010;50(3):235\u201340.","journal-title":"Rev Bras Reumatol"},{"issue":"8","key":"397_CR21","first-page":"1254","volume":"56","author":"D Alp\u00edzar-Rodr\u00edguez","year":"2017","unstructured":"Alp\u00edzar-Rodr\u00edguez D, Pluchino N, Canny G, Gabay C, Finckh A. The role of female hormonal factors in the development of rheumatoid arthritis. Rheumatology (Oxford). 2017;56(8):1254\u201363.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"397_CR22","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1093\/rheumatology\/kez409","volume":"59","author":"E Nikiphorou","year":"2020","unstructured":"Nikiphorou E, de Lusignan S, Mallen C, Roberts J, Khavandi K, Bedarida G, et al. Prognostic value of comorbidity indices and lung diseases in early rheumatoid arthritis: a UK population-based study. Rheumatology (Oxford). 2020;59(6):1296\u2013305.","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"397_CR23","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.3390\/jcm8091416","volume":"8","author":"B Batko","year":"2019","unstructured":"Batko B, Batko K, Krzanowski M, \u017buber Z. Physician Adherence to Treat-to-Target and Practice Guidelines in Rheumatoid Arthritis. J Clin Med. 2019;8(9):1416.","journal-title":"J Clin Med"},{"issue":"10","key":"397_CR24","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1007\/s10067-019-04613-2","volume":"38","author":"J An","year":"2019","unstructured":"An J, Nyarko E, Hamad MA. Prevalence of comorbidities and their associations with health-related quality of life and healthcare expenditures in patients with rheumatoid arthritis. Clin Rheumatol. 2019;38(10):2717\u201326.","journal-title":"Clin Rheumatol"},{"issue":"1","key":"397_CR25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.rbr.2015.01.009","volume":"56","author":"W Marques","year":"2016","unstructured":"Marques W, Cruz VA, Rego J, Silva NA. Influe\u0302ncia das comorbidades na capacidade funcional de pacientes com artrite reumatoide. Rev Bras Reumatol. 2016;56(1):14\u201321.","journal-title":"Rev Bras Reumatol"},{"issue":"7","key":"397_CR26","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.autrev","volume":"18","author":"A Blum","year":"2019","unstructured":"Blum A, Adawi M. Rheumatoid arthritis (RA) and cardiovascular disease. Autoimmun Rev. 2019 Jul;18(7):679\u201390. https:\/\/doi.org\/10.1016\/j.autrev. 2019.05.005. Epub 2019 May 3. Retraction in: Autoimmun Rev. 2020;19(9):102601.","journal-title":"Autoimmun Rev"},{"issue":"10","key":"397_CR27","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1038\/s41591-021-01469-5","volume":"27","author":"AC Medeiros-Ribeiro","year":"2021","unstructured":"Medeiros-Ribeiro AC, Aikawa NE, Saad CGS, Yuki EFN, Pedrosa T, Fusco SRG, et al. Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial. Nat Med. 2021;27(10):1744\u201351.","journal-title":"Nat Med"},{"issue":"8","key":"397_CR28","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1007\/s00296-021-04917-0","volume":"41","author":"S Cherian","year":"2021","unstructured":"Cherian S, Paul A, Ahmed S, Alias B, Manoj M, Santhosh AK, et al. Safety of the ChAdOx1 nCoV-19 and the BBV152 vaccines in 724 patients with rheumatic diseases: a post-vaccination cross-sectional survey. Rheumatol Int. 2021;41(8):1441\u201345.","journal-title":"Rheumatol Int"},{"issue":"5","key":"397_CR29","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1136\/annrheumdis-2021-221490","volume":"81","author":"PM Machado","year":"2022","unstructured":"Machado PM, Lawson-Tovey S, Strangfeld A, Mateus EF, Hyrich KL, Gossec L, et al. Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry. Ann Rheum Dis. 2022;81(5):695\u2013709.","journal-title":"Ann Rheum Dis"},{"key":"397_CR30","doi-asserted-by":"crossref","unstructured":"Tang KT, Hsu BC, Chen DY. Immunogenicity, effectiveness, and safety of COVID-19 vaccines in rheumatic patients: an updated systematic review and meta-analysis. Biomedicines. 2022;10(4):834.","DOI":"10.3390\/biomedicines10040834"},{"issue":"3","key":"397_CR31","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3390\/vaccines10030466","volume":"10","author":"CD Gopaul","year":"2022","unstructured":"Gopaul CD, Ventour D, Thomas D ChAdOx1 nCoV-19 vaccine side effects among healthcare workers in trinidad and tobago. Vaccines (Basel). 2022;10(3):466.","journal-title":"Vaccines (Basel)"},{"issue":"12","key":"397_CR32","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1056\/NEJMoa2110475","volume":"385","author":"N Barda","year":"2021","unstructured":"Barda N, Dagan N, Ben-Shlomo Y, Kepten E, Waxman J, Ohana R, et al. Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting. N Engl J Med. 2021;385(12):1078\u201390.","journal-title":"N Engl J Med"},{"issue":"12","key":"397_CR33","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.3390\/jcm10122629","volume":"10","author":"A Riad","year":"2021","unstructured":"Riad A, Sa\u011f\u0131ro\u011flu D, \u00dcst\u00fcn B, Pokorn\u00e1 A, Klugarov\u00e1 J, Attia S, et al. Prevalence and risk factors of coronavac side effects: an independent cross-sectional study among healthcare workers in Turkey. J Clin Med. 2021;10(12):2629.","journal-title":"J Clin Med"},{"issue":"25","key":"397_CR34","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1056\/NEJMoa2105290","volume":"385","author":"AR Falsey","year":"2021","unstructured":"Falsey AR, Sobieszczyk ME, Hirsch I, Sproule S, Robb ML, Corey L, et al. AstraZeneca AZD1222 Clinical Study Group. Phase 3 safety and efficacy of AZD1222 (ChAdOx1 nCoV-19) covid-19 vaccine. N Engl J Med. 2021;385(25):2348\u201360.","journal-title":"N Engl J Med"},{"issue":"12","key":"397_CR35","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1007\/s00296-021-05017-9","volume":"41","author":"JA Esquivel-Valerio","year":"2021","unstructured":"Esquivel-Valerio JA, Skinner-Taylor CM, Moreno-Arquieta IA, Cardenas-de la Garza JA, Garcia-Arellano G, Gonzalez-Garcia PL, et al. Adverse events of six COVID-19 vaccines in patients with autoimmune rheumatic diseases: a cross-sectional study. Rheumatol Int. 2021;41(12):2105\u201308.","journal-title":"Rheumatol Int"},{"key":"397_CR36","first-page":"100153","volume":"10","author":"N Angkasekwinai","year":"2022","unstructured":"Angkasekwinai N, Sewatanon J, Niyomnaitham S, Phumiamorn S, Sukapirom K, Sapsutthipas S, et al. Comparison of safety and immunogenicity of CoronaVac and ChAdOx1 against the SARS-CoV-2 circulating variants of concern (Alpha, Delta, Beta) in Thai healthcare workers. Vaccine: X. 2022;10:100153.","journal-title":"Vaccine: X"},{"issue":"4","key":"397_CR37","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1136\/annrheumdis-2021-221571","volume":"81","author":"X Li","year":"2022","unstructured":"Li X, Tong X, Yeung WWY, Kuan P, Yum SHH, Chui CSL, et al. Two-dose COVID-19 vaccination and possible arthritis flare among patients with rheumatoid arthritis in Hong Kong. Ann Rheum Dis. 2022;81(4):564\u201368.","journal-title":"Ann Rheum Dis"},{"key":"397_CR38","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1002\/acr2.11336","volume":"3","author":"R Bixio","year":"2021","unstructured":"Bixio R, Bertelle D, Masia M, Pistillo F, Carletto A, Rossini M. Incidence of disease flare after BNT162b2 coronavirus disease 2019 vaccination in patients with rheumatoid arthritis in remission. ACR Open Rheumatol. 2021; 3:832\u201333.","journal-title":"ACR Open Rheumatol"},{"issue":"1","key":"397_CR39","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/art.41924","volume":"74","author":"CM Connolly","year":"2022","unstructured":"Connolly CM, Ruddy JA, Boyarsky BJ, Barbur I, Werbel WA, Geetha D, et al. Disease flare and reactogenicity in patients with rheumatic and musculoskeletal diseases following two-dose SARS-CoV-2 messenger RNA vaccination. Arthritis Rheumatol. 2022;74(1):28\u201332.","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"397_CR40","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.3390\/jpm11121283","volume":"11","author":"L Pinte","year":"2021","unstructured":"Pinte L, Negoi F, Ionescu GD, Caraiola S, Balaban DV, Badea C, et al. COVID-19 vaccine does not increase the risk of disease flare-ups among patients with autoimmune and immune-mediated diseases. J Pers Med (2021) 11(12):1283.","journal-title":"J Pers Med"},{"key":"397_CR41","doi-asserted-by":"publisher","first-page":"6454","DOI":"10.1016\/j.vaccine.2021.09.057","volume":"39","author":"RP Vieira Rezende","year":"2021","unstructured":"Vieira Rezende RP, Braz AS, Guimar\u00e3es MFB, Ribeiro SLE, Abreu Vieira RMR, Bica BE, et al. Characteristics associated with COVID-19 vaccine hesitancy: a nationwide survey of 1000 patients with immune-mediated inflammatory diseases. Vaccine. 2021;39:6454\u201359.","journal-title":"Vaccine"},{"key":"397_CR42","doi-asserted-by":"crossref","unstructured":"Boekel L, Kummer LY, van Dam KPJ, Hooijberg F, van Kempen Z, Vogelzang EH, et al. Adverse events after first COVID-19 vaccination in patients with autoimmune diseases. Lancet Rheumatol. 2021;3(8):e542\u20135.","DOI":"10.1016\/S2665-9913(21)00181-8"},{"key":"397_CR43","doi-asserted-by":"crossref","unstructured":"Sattui SE, Liew JW, Kennedy K, Sirotich E, Putman M, Moni TT, et al. Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 global rheumatology alliance vaccine survey. RMD Open. 2021;7(3):e001814.","DOI":"10.1136\/rmdopen-2021-001814"},{"issue":"10","key":"397_CR44","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1136\/annrheumdis-2021-220732","volume":"80","author":"M Barbhaiya","year":"2021","unstructured":"Barbhaiya M, Levine JM, Bykerk VP, Jannat-Khah D, Mandl LA. Systemic rheumatic disease flares after SARS-CoV-2 vaccination among rheumatology outpatients in New York City. Ann Rheum Dis. 2021;80(10):1352\u201354.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"397_CR45","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1136\/annrheumdis-2019-215882","volume":"79","author":"V Furer","year":"2020","unstructured":"Furer V, Rondaan C, Heijstek MW, Agmon-Levin N, van Assen S, Bijl M, et al. 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. 2020 Jan;79(1):39\u201352.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"397_CR46","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1136\/ard-2023-224742","volume":"83","author":"V Konzett","year":"2024","unstructured":"Konzett V, Kerschbaumer A, Smolen JS, Kristianslund EK, Provan SA, Kvien TK, Aletaha D. Definition of rheumatoid arthritis flare based on SDAI and CDAI. Ann Rheum Dis. 2024 Jan 11;83(2):169\u201376. https:\/\/doi.org\/10.1136\/ard-2023-224742. PMID: 37890977.","journal-title":"Ann Rheum Dis"}],"container-title":["Advances in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-024-00397-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42358-024-00397-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-024-00397-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T11:03:45Z","timestamp":1723460625000},"score":1,"resource":{"primary":{"URL":"https:\/\/advancesinrheumatology.biomedcentral.com\/articles\/10.1186\/s42358-024-00397-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,12]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["397"],"URL":"https:\/\/doi.org\/10.1186\/s42358-024-00397-5","relation":{},"ISSN":["2523-3106"],"issn-type":[{"value":"2523-3106","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,12]]},"assertion":[{"value":"3 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All centers obtained authorization from their respective ethics committees.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authours agree with the publication","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"58"}}